---
authors:
- Elmes, Abigail T
- Hellenbart, Erika L
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/36379478/
file_path: 2022/11/vericiguat-verquvo-for-the-treatment-of-heart-failure.md
issue: '5'
keywords:
- Heart Failure
- Humans
- Heterocyclic Compounds, 2-Ring
- Pyrimidines
- Stroke Volume
last_updated: '2025-07-30'
mesh_terms:
- Humans
- Heterocyclic Compounds, 2-Ring
- Heart Failure
- Pyrimidines
- Stroke Volume
original_format: PubMed
pages: 582-583
patient_population: Adults
peer_reviewed: true
pmid: '36379478'
processed_date: '2025-07-30'
publication_date: '2022-11-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-09'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Vericiguat (Verquvo) for the Treatment of Heart Failure.
topics:
- Family Medicine
volume: '106'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '36379478'
  title: Vericiguat (Verquvo) for the Treatment of Heart Failure.
  authors:
  - last_name: Elmes
    fore_name: Abigail T
    initials: AT
    affiliation: University of Illinois Chicago College of Pharmacy, University of
      Illinois Hospital and Health Sciences System, Chicago, Illinois.
  - last_name: Hellenbart
    fore_name: Erika L
    initials: EL
    affiliation: University of Illinois Chicago College of Pharmacy, University of
      Illinois Hospital and Health Sciences System, Chicago, Illinois.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '106'
    issue: '5'
  publication_info:
    year: '2022'
    month: '11'
    full_date: '2022-11-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Humans
    major_topic: false
  - descriptor: Heterocyclic Compounds, 2-Ring
    major_topic: true
  - descriptor: Heart Failure
    major_topic: true
    qualifiers:
    - qualifier: drug therapy
      major_topic: false
  - descriptor: Pyrimidines
    major_topic: false
  - descriptor: Stroke Volume
    major_topic: false
  publication_types: *id001
---

# Vericiguat (Verquvo) for the Treatment of Heart Failure.

**Authors:** Elmes, Abigail T, Hellenbart, Erika L

**Published in:** American family physician | Vol. 106, No. 5 | 2022-11-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/36379478/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Heterocyclic Compounds, 2-Ring, Heart Failure, Pyrimidines, Stroke Volume

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/36379478/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
